Showing results 1 - 10 of 11
October 5, 2023, Video: “This discussion on the draft merger guidelines with speakers from HKS, MIT, the Dept of Justice, and the Federal Trade Commission took place on Thursday,…
September 13, 2023, Interview: "By my subjective count, among the…
August 2023, Interview: "eemore, as I eagerly read the draft Merger Guidelines, I wonder what they may accomplish. Clearly, the Agencies (the Federal Trade Commission and…
April 19, 2023, Paper: "Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had…
January/February 2023, Interview: "For patients who depend on costly medications to stay healthy, co-pay coupons and patient assistance programs are popular ways to save money at…
September 18, 2022, Paper: "Even among commercially-insured individuals, opioid use disorder (OUD) is undertreated in the US: nearly half receive no treatment within 6 months…
September 2022, Paper: "The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs…
September 6, 2022, Interview: "Policymakers of every leaning have vowed to rein in prescription drug costs, with little success. But research by Leemore Dafny shows how closing a…
September 2022, Audio: "On our 100th episode, Leemore Dafny from Harvard Business School joins Health Affairs Editor-in-Chief Alan Weil to discuss her recent research published in…
February 1, 2022, Paper: "Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such…